ΨΥΧΟΛΟΓΙΑ - Έρευνα και Εφαρμογές ΤΕΥΧΟΣ 3 | Page 134

«ΨΥΧΟΛΟΓΙΑ έρευνα & εφαρμογές» Τόμος 1, Τεύχος 3, 2018 ISSN: 2623-3673
steatosis and fibrosis in northern Italian patients with chronic hepatitis C. J Hepatol
2004; 41: 644–651
Finlayson N, Hayes P, Simpson K, et al. Diseases of the liver and biliary system. In:
Haslett C, Chilvers ER, Hunter JAA & Boon NA (eds). Davidson’s Principles and
Practice of Medicine. London: Churchill Livingstone, 2000
Fischer M, You M, Matsumoto M, Crabb DW. Peroxisome proliferator-activated
receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and
abnormalities in hepatic lipid metabolism in ethanol-fed mice. J Biol Chem 2003; 278:
27997–28004
Fukui H, Brauner B, Bode JC, et al. Plasma endotoxin concentrations in patients with
alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic
assay. J Hepatol 1991; 12(2): 162–169
Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets.
Gastroenterology 2011; 141(5): 1572–1585
Gressner AM, Schuppan D. Cellular and molecular pathobiology, pharmacological
intervention, and biochemical assessment of liver fibrosis. In: Bircher J, Benhamou J-
P, McIntyre N, Rizzetto M & Rodes J (eds). Oxford Textbook of Clinical Hepatology.
2 nd ed. Oxford, Oxford University Press, 1999, vol 2, pp. 607–627
Harris HE, Ramsay ME, Andrews N, Eldridge KP. Clinical course of hepatitis C virus
during the first decade of infection: cohort study. BMJ 2002; 324: 450–453
Hatton J, Burton A, Nash H, et al. Drinking patterns, dependency and life-time
drinking history in alcohol-related liver disease. Addiction 2009; 104(4): 587–592